Psychiatr. praxi. 2013;14(4):164-166
Anhedonia - adverse effect, residnal symptom or a sign of stability?
- Med Avante Inc. A-Shine s. r. o.
Anhedonia is the core symptom of depression and several other psychiatric disorders such as schizophrenia, substance abuse etc. Anhedonia
could be taken into consideration as residual symptom of depression as well. As residual symptoms should be treated, because of
risk of worsening in the future. Some patiens, mainly long term SSRI´s treated, refer to fear of feeling emotions. They consider emotions
being weaknes and risk of repeated development of depression. Decision making has been shown in two case-reports with respect to
patient evaluation. Difference between SSRI´s and agomelatine has been emphasized.
Keywords: anhedonia, SSRI, agomelatine, major depression
Published: November 1, 2013 Show citation
References
- Hartl P. Psychologický slovník, Nakladatelství Budka, Praha 1994.
- Snaith P. Anhedonia: a neglected symptom of psychopathology. Psychol Med 1993; 23: 957-966.
Go to original source... 
Go to PubMed... - Price J, Cole V, Goodwin G. Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study. Br J Psychiatry 2009; 195: 211-217. Go to original source... Go to PubMed...
- Song C, Leonard BE. Základy psychoneuroimunologieJohn Willey & Sons Ltd 2000, česky Artax 2002: 275.
- Padala P, Padala K, Monga V, et al. Reversal of SSRI-associated apathy syndrome by discontinuation of therapy. An n Psychother 2012: 46, e8. Go to original source... Go to PubMed...
- Dichter G. Anhedonie in inupolar major depressive disorder: A review. Open Psychiatr J 2010; 4: 1-9. Go to original source...
- Miller MJ, Vorel SR, Tranguch AJ, et al. Anhedonia after selective bilateral lession of the global pallidus. Am J Psychiatry 2006; 163: 785-788. Go to original source... Go to PubMed...
- Keedwell PA, Andrew C, Williams SC, Brammer MJ, Philips ML. The neural correlates of anhedonia in major depressive disorder. Biol Psychiatry 2005; 58: 843-853. Go to original source... Go to PubMed...
- Tremblay LK, Naranjo CA, Graham SJ, et al. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry 2005; 62: 1228-1236. Go to original source... Go to PubMed...
- Smith GS, Ma Y, Dhawan V, Chaly T, Eidelberg D. Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography. Synapse 2009; 63(1): 1-6. Go to original source... Go to PubMed...
- Prisco S, Esposito E. Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area. Brit J Pharm, 2009; 116(2): 1923-1931. Go to original source... Go to PubMed...
- Janů L, Racková S. Léčba deprese pacientů se schizofrenií. Psychiatr. pro Praxi, 2008; 9(4): 160-163.
- Di Giannantonio M, Di Iorio G, Guglielmo R, De Berardis D, Conti CM, Acciavatti T, Cornelio M, Martinotti G. Major depressive disorder, anhedonia and agomelatine: an open-label study. J Biol Regul Homeost Agents. 2011; 25(1): 109-114. Go to PubMed...
- Martinotti GSepede G, Gambi F, Di Iorio G, De Berardis D, Di Nicola M, Onofrj M, Janiri L, Di Gianantonnio M. Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder. A Pilot Study. J Clin Psychopharmacol 2012; 32: 487-491. Go to original source... Go to PubMed...